Arcus Biosciences - ASCO 2023: Arcus Update on Anti-TIGIT Program & ARC-7 Results

Investor Contact

Investor Email Alerts

To receive notifications via email, enter your email address and select at least one subscription below. After submitting your information, you will receive an email. You must click the link in the email to activate your subscription. You can sign up for additional subscriptions at any time.

* Required

Email Address *

Mailing Lists *

Press Releases

Events

SEC Filings

EOD Stock Quote